furosemide has been researched along with albuterol in 34 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (8.82) | 18.7374 |
1990's | 8 (23.53) | 18.2507 |
2000's | 10 (29.41) | 29.6817 |
2010's | 13 (38.24) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Aleo, MD; Bonin, PD; Luo, Y; Potter, DM; Swiss, R; Will, Y | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
Keller, N; Larsen, J; Sykulski, R | 1 |
Cremona, G; Dinh Xuan, AT; Higenbottam, TW; Lockhart, A; Wood, AM | 1 |
Baricevic, K; Darley, P; Guittard, G; Place, V; Pruitt, B; Ramans, A | 1 |
Mutina, ES | 1 |
D'Onofrio, F; Giugliano, D; Torella, R | 1 |
Neuvonen, PJ; Roivas, L | 1 |
Chin, T; Franchi, L; Nussbaum, E | 1 |
Charfi, R; Dinh-Xuan, AT; Lockhart, A; Mialon, P; Regnard, J | 1 |
Ayau, EL; Fujiwara, N; Iwamoto, LM; Lavallee, SL; Nakamura, KT; Wilson, VL | 1 |
Chapman, KR; Molfino, NA; Nannini, LJ; Pendino, JC; Slutsky, A | 1 |
Christ, MJ; Fujiwara, N; Gelber, RP; Iwamoto, LM; Marinkovich, GA; Nakamura, KT | 1 |
Bayly, WM; Hakala, JE; Hines, MT; Schott, HC; Sides, RH; Slocombe, RF | 1 |
Araújo, F; Carlos, AG; Garcês, S; Rego, F; Soares, JL | 1 |
Coppejans, HC; Corthouts, B; Jorens, PG; Saldien, V; Van de Heyning, P; Vercauteren, MP | 1 |
Belen, B; Dalgic, B; Oguz, A; Okur, A | 1 |
Andaluz, A; Berjano, E; Burdío, F; Burdío, JM; Cáceres, M; Castellví, Q; Dorcaratto, D; Grande, L; Ivorra, A; Moll, X; Pañella, C; Quesada, R; Sánchez-Velázquez, P; Trujillo, M; Villanueva, A | 1 |
Buchiboyina, A; Deshmukh, M; Jasani, B; Patole, S | 1 |
Banzett, RB; Lansing, RW; O'Donnell, CR; Schwartzstein, RM | 1 |
5 review(s) available for furosemide and albuterol
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Treatment of bronchial asthma].
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Albuterol; Aminophylline; Asthma; Bronchitis; Cardiac Glycosides; Chronic Disease; Ephedrine; Ethacrynic Acid; Furosemide; Glucocorticoids; Histamine H1 Antagonists; Iontophoresis; Isoproterenol; Metaproterenol; Pneumonia; Pteridines; Pulmonary Heart Disease; Receptors, Adrenergic; Sinusitis; Terbutaline; Tonsillitis | 1974 |
Prostaglandins and the alpha-cell.
Topics: Albuterol; Animals; Arginine; Aspirin; Blood Glucose; Diabetes Mellitus; Furosemide; Glucagon; Guinea Pigs; Humans; Indomethacin; Islets of Langerhans; Kinetics; Propranolol; Prostaglandins; Prostaglandins E; Rats | 1981 |
Capillary leakage syndrome: a case report and a review.
Topics: Adult; Albuterol; Anti-Bacterial Agents; Capillary Leak Syndrome; Cytokines; Drug Therapy, Combination; Edema; Erythrocyte Transfusion; Fatal Outcome; Furosemide; Gastrointestinal Hemorrhage; Hodgkin Disease; Humans; Ipratropium; Male; Pancytopenia; Platelet Transfusion; Prednisolone | 2002 |
Strategies for managing transient tachypnoea of the newborn - a systematic review.
Topics: Administration, Inhalation; Albuterol; Bronchodilator Agents; Diuretics; Epinephrine; Female; Furosemide; Humans; Infant, Newborn; Length of Stay; Male; Noninvasive Ventilation; Randomized Controlled Trials as Topic; Risk Factors; Transient Tachypnea of the Newborn; Treatment Outcome | 2017 |
4 trial(s) available for furosemide and albuterol
Article | Year |
---|---|
Human buccal assay for evaluation of the mucosal irritation potential of drugs.
Topics: Administration, Topical; Adult; Albuterol; Anti-Inflammatory Agents, Non-Steroidal; Female; Furosemide; Gels; Humans; Male; Methyldopa; Middle Aged; Mouth Mucosa; Prazosin; Prognosis; Propranolol; Time Factors | 1988 |
Reversal of bronchial obstruction in children with mild stable asthma by aerosolized furosemide.
Topics: Administration, Inhalation; Adolescent; Albuterol; Analysis of Variance; Asthma; Child; Chronic Disease; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Female; Furosemide; Humans; Male; Pilot Projects; Respiratory Function Tests | 1994 |
Locally deposited but not inhaled frusemide reduces nasal potential difference in healthy subjects.
Topics: Administration, Inhalation; Administration, Topical; Adult; Albuterol; Amiloride; Bumetanide; Double-Blind Method; Electrophysiology; Furosemide; Humans; Male; Nasal Mucosa; Potentiometry | 1993 |
Effect of inhaled furosemide in acute asthma.
Topics: Adult; Aerosols; Albuterol; Asthma; Bronchodilator Agents; Double-Blind Method; Female; Furosemide; Humans; Male; Peak Expiratory Flow Rate; Time Factors | 1998 |
25 other study(ies) available for furosemide and albuterol
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Human drug-induced liver injury severity is highly associated with dual inhibition of liver mitochondrial function and bile salt export pump.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Chemical and Drug Induced Liver Injury; Humans; Male; Mitochondria, Liver; Rats; Rats, Sprague-Dawley; Severity of Illness Index | 2014 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
Effects of dobutamine and salbutamol on haemodynamics and atrial natriuretic factor in patients with severe congestive heart failure.
Topics: Adult; Aged; Albuterol; Atrial Natriuretic Factor; Blood Pressure; Cardiac Output; Dobutamine; Female; Furosemide; Heart Failure; Heart Rate; Hematocrit; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardium; Pulmonary Wedge Pressure | 1991 |
The alpha 1-adrenergic agonist methoxamine and the "loop" diuretic frusemide reduce nasal potential difference.
Topics: Adult; Albuterol; Amiloride; Female; Furosemide; Humans; Ion Exchange; Male; Membrane Potentials; Methoxamine; Nasal Mucosa; Potentiometry | 1991 |
Drug adsorption onto activated charcoal as a means of formulation.
Topics: Adsorption; Albuterol; Charcoal; Chemical Phenomena; Chemistry, Pharmaceutical; Chemistry, Physical; Clonidine; Furosemide; Kinetics; Metoprolol; Pindolol; Sympatholytics | 1994 |
Tachyphylaxis to furosemide in isolated airways of guinea pigs.
Topics: Albuterol; Animals; Carrier Proteins; Female; Furosemide; Guinea Pigs; In Vitro Techniques; Male; Muscle Contraction; Rubidium; Sodium-Potassium-Chloride Symporters; Tachyphylaxis; Trachea | 1996 |
Cross-desensitization to furosemide and salbutamol in isolated neonatal guinea pig airways.
Topics: Acetylcholine; Albuterol; Animals; Animals, Newborn; Bronchodilator Agents; Cyclic AMP; Drug Tolerance; Furosemide; Guinea Pigs; Isometric Contraction; Muscle Relaxation; Potassium Channel Blockers; Potassium Channels; Rubidium Radioisotopes; Trachea | 1999 |
Effects of inhalation of albuterol sulphate, ipratroprium bromide and frusemide on breathing mechanics and gas exchange in healthy exercising horses.
Topics: Albuterol; Animals; Bronchodilator Agents; Cross-Over Studies; Diuretics; Furosemide; Horses; Ipratropium; Nebulizers and Vaporizers; Oxygen Consumption; Physical Conditioning, Animal; Pulmonary Gas Exchange; Respiratory Mechanics; Vascular Resistance | 2001 |
Acute respiratory distress after upper airway obstruction following palatoplasty.
Topics: Airway Obstruction; Albuterol; Bronchodilator Agents; Child; Diuretics; Furosemide; Humans; Male; Palate, Soft; Postoperative Complications; Respiratory Insufficiency; Tomography, X-Ray Computed | 2003 |
A complication to be aware of: hyperkalaemia following propranolol therapy for an infant with intestinal haemangiomatozis.
Topics: Albuterol; Angiography; Biopsy, Needle; Drug Therapy, Combination; Fluid Therapy; Follow-Up Studies; Furosemide; Gastrointestinal Hemorrhage; Hemangioma, Capillary; Humans; Hyperkalemia; Immunohistochemistry; Infant; Male; Melena; Monitoring, Physiologic; Propranolol; Risk Assessment; Severity of Illness Index; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
Irreversible electroporation of the liver: is there a safe limit to the ablation volume?
Topics: Albuterol; Animals; Cell Membrane Permeability; Electrochemotherapy; Furosemide; Hyperkalemia; Liver; Liver Neoplasms, Experimental; Male; Mice; Mice, Inbred C57BL; Mice, Nude; Organ Size; ROC Curve; Sodium Bicarbonate | 2016 |
Aerosol furosemide for dyspnea: High-dose controlled delivery does not improve effectiveness.
Topics: Administration, Inhalation; Adolescent; Adult; Aerosols; Albuterol; Dose-Response Relationship, Drug; Dyspnea; Female; Furosemide; Humans; Inhalation; Male; Models, Biological; Pain Measurement; Palliative Care; Sodium Potassium Chloride Symporter Inhibitors; Tidal Volume; Treatment Outcome; Young Adult | 2018 |